Concerning Correlation: GMO Mosquitoes Caused Zika Virus Outbreak?

If there was ever an event that could have the GMO industry really worried – this could be it.

The massive outbreak of the Zika Virus is causing a global panic, but some keen observers may have just found the source of the problem.

In 2012, British biotech company Oxitec released genetically modified mosquitoes (GMMs) with the aim of reducing the overall mosquito population that spreads diseases like dengue fever and the Zika Virus in northeast Brazil – ground zero of the current outbreak of Zika.

Watch a video of this report here:

Dr Helen Wallace, director of GeneWatch, told the Guardian in 2012, “It’s a very experimental approach which has not yet been successful and may cause more harm than good.”

Oxitec’s program aimed to release only male Aedes mosquitoes into the wild, so they would in turn produce offspring with virus-carrying female counterparts. This offspring would then die off, hopefully, before breeding age due to the GM coding in their genes.

This die-off would only happen as long as the antibiotic tetracycline wasn’t present, which would override the GM DNA.

Point of release, and center of the outbreak. Coincidence? 

RT reports that the known survival rate of the GMMs was already at 5%, and the antibiotic can be found in nature, showing up in soil, surface water, and food, with some research stating that the GMM survival rate could potentially increase to 15 percent. So, there would be an extra 15% more disease-spreading mosquitoes than there were before the release of the GMMs.

Jaydee Hanson, a senior policy analyst at the US-based Center for Food Safety, told Bloomberg News:

“They’re introducing into the ecosystem some genetic constructs that have never been there before,” and that, “it doesn’t solve the problem”, because other species of mosquito could still carry the Zika virus anyway.

The Zika outbreak has already been interpreted as a sort of eugenics WMD, as it has promoted a disturbing call for a no-child policy throughout many South American countries, so this concerning correlation between Zika’s ground zero and the release site of the GMMs must be adequately investigated.

Is the survival rate of the GMMs perhaps even higher than 15%? How can we prove that the GMMs have been responsible for the disastrous spread of the disease? If that is proven, how do we begin to hold Oxitec accountable?

How much money is now being pumped into private pharmaceutical companies to produce a vaccine for Zika? What will that mean for their share prices?


Articles Par : 21st Century Wire

Avis de non-responsabilité : Les opinions exprimées dans cet article n'engagent que le ou les auteurs. Le Centre de recherche sur la mondialisation se dégage de toute responsabilité concernant le contenu de cet article et ne sera pas tenu responsable pour des erreurs ou informations incorrectes ou inexactes.

Le Centre de recherche sur la mondialisation (CRM) accorde la permission de reproduire la version intégrale ou des extraits d'articles du site sur des sites de médias alternatifs. La source de l'article, l'adresse url ainsi qu'un hyperlien vers l'article original du CRM doivent être indiqués. Une note de droit d'auteur (copyright) doit également être indiquée.

Pour publier des articles de en format papier ou autre, y compris les sites Internet commerciaux, contactez: [email protected] contient du matériel protégé par le droit d'auteur, dont le détenteur n'a pas toujours autorisé l’utilisation. Nous mettons ce matériel à la disposition de nos lecteurs en vertu du principe "d'utilisation équitable", dans le but d'améliorer la compréhension des enjeux politiques, économiques et sociaux. Tout le matériel mis en ligne sur ce site est à but non lucratif. Il est mis à la disposition de tous ceux qui s'y intéressent dans le but de faire de la recherche ainsi qu'à des fins éducatives. Si vous désirez utiliser du matériel protégé par le droit d'auteur pour des raisons autres que "l'utilisation équitable", vous devez demander la permission au détenteur du droit d'auteur.

Contact média: [email protected]